Pick a time period -
No more available filters You need to apply a filter before selecting newsroom

Use our filters to get your customized news. Save and subscribe to as many filters as you want, get the news that YOU are interested in right in your mailbox, RSS feed or in your personalized dashboard. Share your stories, news, multimedia and pressreleases and get a wider audience with news.cision.com.

Interim report January – September 2021

Third quarter 2021 · Net sales increased to SEK 3,215m (3,105) corresponding to organic sales growth of 3%. · Operating profit increased to SEK 228m (195), corresponding to an operating margin of 7.1% (6.3). · Changes in exchange rates positively impacted operating profit by SEK 5m. · Profit after tax amounted to SEK 170m (132), corresponding to earnings per share after dilution of SEK 1.01 (0.78). · Operating cash flow amounted to SEK 123m (484).The Nordic and Central European kitchen markets remained strong following the underlying demand for home renovations. In the UK,

Sedana Medical’s Nomination committee appointed

Sedana Medical AB (publ) today publish that in accordance with the resolution of the Annual General Meeting on May 10, 2021, the Chairman of the Board has contacted the company’s three largest shareholders or group of shareholders in terms of votes to form a Nomination Committee. These shareholders have been invited to appoint one representative each who, together with the Chairman of the Board, will comprise the Nomination Committee.Sedana Medical's Nomination Committee for the 2022 Annual General Meeting consists of: · Thomas Eklund, Chairman of the Board · Karl Tobieson,

BioStock: BibbInstruments aims high in cancer diagnostics industry

Early detection and diagnostics of cancer is one of the best tools for combating what remains one of the world’s deadliest diseases. Swedish medtech company BibbInstruments develops the EndoDrill Model X, a medical device with the potential to make a significant dent in the cancer diagnostics industry while addressing a market potentially worth close to 1 billion USD, according to the company.Read the article at biostock.se: https://www.biostock.se/en/2021/10/bibbinstruments-aims-high-in-cancer-diagnostics-industry/ This is a press release from BioStock - Connecting Innovation &

Gapwaves receives a new order from HELLA

Gapwaves has received a follow-up order for a project for 77 GHz antennas intended for automotive radar. The delivery includes design / development and production of antenna prototypes based on an updated antenna specification for a 77 GHz corner radar. The value of the order is 3MSEK with expected delivery to take place during the first quarter of 2022.Over the past year, HELLA has evaluated Gapwave's technology through several design and prototype projects. As a deepening of the collaboration, a license and development agreement were signed in June 2021 between Gapwaves and HELLA. As part

NextCell increases market potential and reduces the risk of ProTrans' clinical trial program in type 1 diabetes

NextCell Pharma AB ("NextCell" or the "Company") updates the strategy for the clinical trial program in type 1 diabetes with ProTrans. The aim is to increase potential while reducing the risk. This can be achieved by waiting for preliminary safetydata from the approved ProTrans-Young pediatric trial before submitting the application for ProTrans-3, scheduled for H2 2022.Advantages of the updated strategy for future application for marketing approval are: · Lower age limit for treatment is desirable and could potentially double the intitial market · Increased long term data from

New technology to reduce blood loss after injury

When a critical injury to an arm or leg results in intense blood loss, an emergency tourniquet must be applied. Through innovative solutions, competence in industrialisation and eco-design, Semcon in Norway is supporting health tech company Aristeia in the development of its unique tourniquet for bleeding control.Aristeia’s patented solution is easy and quick to use, providing a market leading pressure distribution thanks to the geared pull cord mechanism, the robust strap guide, and the on-device user instructions. The optimised pressure distribution reduces pain and discomfort.  “This

Tamro medicines go by PostNord’s biogas trucks – driven by climate goals and legislation governing the transport of medicines

Tamro’s logistics are driven by climate goals and legislation governing the transport of medicines and health products. With Tamro’s partner Post Nord’s biogas-powered vehicles, transport is safe, cost-effective and climate friendly.Some of the transports of Tamro, Finland’s leading medicines and health and wellbeing products distributor and service provider, reach customers with the help of Gasum biogas. Since Tamro’s customers can be found across Finland from large cities and built-up areas to the smallest localities, many transport kilometers are clocked up each week. Logistics are a

Hemsö acquires two nursing homes in Germany

Hemsö is acquiring two nursing homes, in two separate transactions, in the state of Bavaria in Germany. The investment amounts to EUR 28 million.The acquisitions consist of one nursing home in the city of Pullach, in the outskirts of Munich, and one nursing home in Pfronten, close to the Austrian border.  The facility in Pullach has been leased by Gemeinnützige Paritätische Altenhilfe in a 25-year rental agreement. The facility in Pfronten has been leased by Korian in a six-year rental agreement. “We are pleased with these acquisitions in Bavaria, a state where we want to grow our

Attendo’s report for the third quarter 2021: Increased demand and good organic growth

Attendo’s report for the third quarter of 2021 shows continued good organic growth and a higher operating profit compared to the same period of 2020. The improvement in profit is led by Scandinavia, where higher demand has led to a clear improvement in occupancy compared to the spring. In Finland, the improvement slowed down somewhat during the quarter, mainly due to temporary shortages of substitutes staff during the summer months.Comments from Martin Tivéus, president and CEO “After a long period defined by the pandemic, we are pleased that we have been able to fill more beds in

Mycronic receives order for three SLX mask writers

Mycronic AB (publ) has received an order for three SLX mask writers from an existing customer in the US. The order value is in the range of USD 20-24 million. Delivery of the first system is planned for the fourth quarter of 2022, while delivery of the second and third system is planned for the first quarter of 2023. The SLX laser mask writer meets rising demand for photomasks for the semiconductor industry and a future need for replacement and modernization. Photomasks manufactured by laser mask writers are of high importance and account for 70-75 percent of all photomasks produced for

TIE Kinetix Earns Microsoft Co-Sell Ready Status

TIE Kinetix  announced today that they have received Microsoft Co-Sell Ready status for their fully integrated supply chain solution, EDI-2-FLOW for Dynamics 365. The achievement further raises TIE Kinetix’s status within the Microsoft Gold partner community and enables the company to boost product visibility among target groups through joint activities with Microsoft.TIE Kinetix recently announced that EDI-2-FLOW for Dynamics 365 is available on Microsoft AppSource, providing Dynamics 365 Finance & Supply Chain Management (SCM) users with an out-of-the-

SKF Nine-month report 2021: Industrial maintains its strong momentum; Automotive hit by customer supply constraints

Gothenburg, 26 October 2021 Rickard Gustafson, President and CEO: “The third quarter saw continued solid demand. Our Industrial business, which represents approximately 75% of sales, main­tained its strong momentum, despite challenges from logistics constraints and cost inflation. Our Automotive business was significantly impacted by reduced production amongst key cus­tomers, especially in September. Throughout the whole business, we have worked hard and diligently to mitigate the negative impact of these external circumstances. Organic growth in the quarter was 8%, with Industrial

Finnair Group Interim Report 1 January – 30 September 2021

Finnair Plc             Interim Report            26 October 2021 at 9.00 a.m. EEST Travel restarted in Europe – half of Finnair markets are open. Operating cash flow turned positive for the first time since Q4 2019. July – September 2021 · Earnings per share were -0.08 euros (-0.15)*. · Revenue increased by 104.7% to 199.4 million euros (97.4). · Comparable operating result was -109.1 million euros (-167.0). Operating result was -106.0 million euros (-183.1). · Cash funds were 1,181.4 million euros (31 Dec 2020: 823.7) and equity ratio was 14.1 per cent (31 Dec 2020: 24.

Peab builds apartments in Langesund

Peab has been commissioned to build apartments in the housing project Smietangen in Langesund. The customer is Smietangen Utbygging and the contract is worth NOK 119 million.The entire project comprises building 39 apartments divided into seven detached buildings. Three of the buildings will be built on the shoreline and four of them on top of a parking garage. The buildings will have waterborne underfloor heating installed that comes from a local heating system which was established in the first construction phase of the project. The detached shoreline buildings will be built on bedrock,

Finnair’s financial calendar and AGM in 2022

Finnair Plc            Stock Exchange Release            26 October 2021 at 9.00 a.m. EEST  A bulletin on Finnair Plc’s financial statements for 2021 will be published on Thursday 17 February 2022 at 09:00 a.m. EET. The financial statements 2021 will be published later the same day.  The Annual General Meeting will be held on Thursday 24 March 2022 at 3:00 p.m. EET in Helsinki. An official invitation to the meeting will be published later.  The full financial calendar 2022 is as follows:  ·Financial Statements Bulletin for 2021 on Thursday 17 February 2022  ·Interim

Interim report third quarter 2021

OX2 AB (publ) reports its result for the third quarter of 2021 todayQ3 2021 · Net sales amounted to SEK 600 million (2,050). · Operating income amounted to SEK 24 million (171), operating income adjusted for listing expenses amounted to SEK 25 million (171). · The operating margin amounted to 4.1% (8.4), operating margin adjusted for listing expenses amounted to 4.2% (8.4). · Profit for the period totalled SEK 15 million (132). · Earnings per share amounted to SEK 0.06 (0.53). · Cash flow from operating activities amounted to SEK 143 million (81). · 614 MW of project

STOREBRAND ASA: Reminder - Invitation to Result Presentations Q3 2021

In connection with the release of the results for Q3 2021, Storebrand invites to the following events: Tomorrow, Wednesday 27 October 2021 07.30 CESTRelease of stock exchange notification. Press release, quarterly report and analyst presentation will be available on www.storebrand.com/ir. 10.00 CESTLive investor and analyst conference in English in a combined webcast and conference call. The presentation will be available on demand afterwards. Link to webcast  Participants who would like to

DBP International: Out-licensing to YRRO rights for an international patent for the use of ferrous succinate

Double Bond Pharmaceuticals AB (publ) (“DBP”) has entered into an agreement with YRRO Ltd (“YRRO”) to sell the license for use of its intellectual properties including international patent application for active substance ferrous succinate, marketed as “Inofer”, in the USA, Japan, China and the EU (excluding the Nordic countries). Clinical trial results undertaken by DBP indicate that ferrous succinate (“Inofer”) markedly and significantly improved iron uptake, iron saturation, and iron stores in patients with heart failure and iron deficiency. Inofer is a low-cost oral alternative to

Össur hf: Interim report Q3 2021

Announcement no. 17/2021 Interim report Q3 2021 26 October 2021 Jon Sigurdsson, President & CEO, Comments: “EMEA and APAC continued to perform well, in line with expectations, while the COVID-19 Delta variant primarily impacted sales in Americas, which is our largest market. Although organic growth was impacted by softer sales in Americas, the performance in other key markets strengthens our belief that the long-term prospects and underlying fundamental drivers of the Prosthetics and B&S markets are not expected to change and that we are well on our way. As innovation and

Husqvarna Group to acquire Orbit Irrigation in the U.S., creating the global market leader in residential watering

Husqvarna Group has signed an agreement to acquire Orbit Irrigation, a leading provider of residential watering solutions in North America. Orbit will become part of Husqvarna Group’s Gardena Division, establishing a global leader and creating growth opportunities for both brands.Orbit’s net sales during the last 12 months amounted to approximately USD 320m with an operating margin slightly below Husqvarna Group average. The purchase price corresponds to an enterprise value of USD 480m on a cash and debt-free basis and will be financed through existing cash and undrawn credit facilities.

Ponsse's Interim Report for 1 January - 30 September 2021

– Net sales amounted to EUR 523.4 (Q1-Q3/2020 431.4) million.– Q3 net sales amounted to EUR 172.6 (Q3/2020 155.0) million.– Operating result totalled EUR 56.3 (Q1-Q3/2020 43.4) million, equalling 10.8 (10.1) per cent of net sales.– Q3 operating result totalled EUR 20.0 (Q3/2020 21.6) million, equalling 11.6 (13.9) per cent of net sales.– Profit before taxes was EUR 54.7 (Q1-Q3/2020 22.7) million.– Cash flow from business operations was EUR 50.1 (15.6) million.– Earnings per share were EUR 1.40 (0.52).– Equity ratio was 61.8 (47.5) per cent.– Order books stood at EUR 402.3 (

FlexQubes report for the third quarter 2021

THIRD QUARTER 2021 · Order intake increased by 263 percent to 40.6 MSEK (11.2). Adjusted for foreign exchange rate effects between the comparison periods, orders received increased by 254 percent. · Net sales increased by 67.1 percent to 23.5 MSEK (14.1). Adjusted for foreign exchange rate effects between the comparison periods, net sales increased by 64.3 percent. · Operating profit before depreciation (EBITDA) amounted to -8.0 MSEK (-8.4) and operating profit before financial items (EBIT) amounted to -9.2 MSEK (-9.7). · Profit before tax amounted to -9.3 MSEK (-9.7). ·

Nilar and RRK announce establishment of a Nilar battery production plant in Paldiski, Estonia

Nilar International (“Nilar”) is progressing to establish a battery and energy storage production site in Estonia in cooperation with Riigiressursside Keskus OÜ (“RRK Logistics Parks”).Estonian industrial and logistics real estate company Riigiressursside Keskus OÜ (RRK Logistics Parks) is building a factory for Nilar, Nilar’s second plant after Gävle in Sweden, to produce batteries for stationary energy storage systems.According to a recently signed agreement between Nilar and RRK, a 1st stage of an eventual 7000 sqm factory building at Lõuna 6b, Paldiski is currently being built,

Another strong quarter

President & CEO Henrik Hjalmarsson comments on the third quarter of 2021”Inwido’s growth journey continues, and it is with great satisfaction that we report our tenth consecutive quarter with increasing margins. We also delivered our highest quarterly profit to date. We achieved a double-digit increase in sales, driven by strengthened market positions and good demand. During the quarter, our capacity utilization increased, the mix was positive and increasing prices for raw material were met with proactive price adjustments. This has successfully defended and strengthened our margins”. “

There are no items matching the current filter
There are no more items matching the current filter
Back to top